Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Pediatrics
Published in: European Journal of Pediatrics 4-5/2004

01-04-2004 | Short Report

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C

Authors: Magdalena Figlerowicz, Wojciech Sluzewski, Arleta Kowala-Piaskowska, Iwona Mozer-Lisewska

Published in: European Journal of Pediatrics | Issue 4-5/2004

Login to get access

Excerpt

Combined interferon alpha-ribavirin therapy proved to be effective in almost 50% of children with chronic hepatitis C. There was no obvious correlation between the patients’ characteristics and the final outcome of the therapy. …
Literature
1.
2.
Christensson B, Wiebe T, Akesson A, Widell A (2000) Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis 30: 585–586CrossRefPubMed
3.
Farci P, Strazzera R, Alter HJ, Farci S, Degioannis D, Coiana A, Peddis G, Usai F, Serra G, Chessa L, Diaz G, Balestrieri A, Purcell R (2002) Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Nat Acad Sci USA 99: 3081–3086CrossRefPubMed
4.
Figlerowicz M, Alejska M, Kurzynska-Kokorniak A, Figlerowicz M (2003) Genetic variability – the key problem in prevention and therapy of RNA-based virus infections. Med Res Rev 23: 488–518CrossRefPubMed
5.
Kondel RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431–435PubMed
6.
Wirth S, Lang T, Gehring S, Gerner P (2002) Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36: 1280–1284CrossRefPubMed
Metadata
Title
Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C
Authors
Magdalena Figlerowicz
Wojciech Sluzewski
Arleta Kowala-Piaskowska
Iwona Mozer-Lisewska
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 4-5/2004
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-004-1418-9

Other articles of this Issue 4-5/2004

European Journal of Pediatrics 4-5/2004 Go to the issue

Short Report

Thyroid volume and urinary iodine excretion in schoolchildren in North-Eastern Bosnia

Original Paper

Risk factors for recurrent urinary tract infection in 4,332 Belgian schoolchildren aged between 10 and 14 years

Original Paper

Short stature in children with an apparently normal male phenotype can be caused by 45,X/46,XY mosaicism and is susceptible to growth hormone treatment

Original Paper

Bilateral urinary calculi after treatment with a silicate-containing milk thickener

Original Paper

Severe neurological impairment in hereditary methaemoglobinaemia type 2

Review

Diagnostic strategies for the evaluation of asymmetry in infancy—a review